Search & AI Visibility Audit
A full GEO and SEO assessment of biogenesiscenter.com measured against every clinic competing for Panama stem cell therapy searches — including the AI engines that now answer patients before they ever reach a website.
Section 01
Our website is technically better built than the market leader's — faster, fully readable by AI crawlers, cleaner markup. What we do not have is an entity: outside our own pages, almost nothing on the internet corroborates that BioGenesis exists. Google and every AI engine rank medical information by who stands behind it, and by that measure we are invisible.
Structure scores roughly 75 out of 100. Authority scores roughly 20. For medical search, authority is the constraint that decides everything else.
Section 02
Authority Score is Semrush's 0–100 measure of a domain's ranking strength, driven mainly by how many independent websites reference it. Every clinic competing for our patients scores higher than we do.
Swipe the table sideways for all columns
| Clinic | Authority | Backlinks | Referring domains | Keywords | Traffic / mo |
|---|---|---|---|---|---|
| DVC Stem Cayman Islands | 38 | 13,055 | 1,743 | 8,333 | 20,039 |
| Stem Cell Institute Panama — cellmedicine.com | 34 | 10,027 | 1,082 | 4,512 | 12,254 |
| BioXcellerator Colombia | 29 | 3,884 | 979 | 4,387 | 2,620 |
| Auragens Panama | 26 | 1,324 | 450 | 1,604 | 1,382 |
| Stemwell Panama | 20 | 1,641 | 333 | 801 | 600 |
| neilriordan.com personal brand | 16 | 711 | 190 | 565 | 163 |
| Medistem Panama research arm | 13 | 523 | 190 | 24 | 0 |
| Regenerate Panama | 12 | 631 | 178 | 327 | 644 |
| PCT Panama | 9 | 15,439 | 287 | 580 | 11 |
| BioGenesis biogenesiscenter.com | 2 | 529 | 106 | 16 | 0 |
PCT Panama has more backlinks than the market leader — 15,439 — from only 287 websites, and earns an Authority Score of 9 with eleven visitors a month. That is what a purchased or spam-heavy link profile buys. The metric that matters is how many distinct, credible websites reference us, never the raw link count.
The Riordan organization runs the clinic site, a personal brand site, and a research site as separate properties that each earn their own references. We also have three domains — but ours serve identical content, so instead of compounding, they divide our signal. Same architecture, opposite result.
Auragens reaches Authority Score 26 with only 450 referring domains, and Stemwell reaches 20 with 333. We do not need DVC Stem's 1,743 websites to compete. The realistic sequence is Regenerate Panama's tier at roughly 178 domains, then Stemwell's 333, then Auragens' 450.
Section 03
The Stem Cell Institute in Panama City is the entity we are actually competing against for the Panama patient. It is worth understanding precisely how their position is constructed, because roughly half of it is copyable and the other half is not.
Swipe the table sideways for all columns
| Property | Role | Authority | Ref. domains | Traffic / mo |
|---|---|---|---|---|
| cellmedicine.com | The clinic. Treatments, conditions, booking. | 34 | 1,082 | 12,254 |
| neilriordan.com | The scientist. Books, speaking, publications. | 16 | 190 | 163 |
| medistempanama.com | The research arm. Laboratory and study identity. | 13 | 190 | 0 |
The mechanism is worth stating plainly, because it is the opposite of our situation. A journalist writing about the scientist links to the personal site. A study or citation points at the research arm. A patient or directory links to the clinic. Three different kinds of reference that would otherwise compete for one page instead accumulate on three, and the three interlink so the authority pools. Our three domains serve identical content, so they produce duplicate signals that divide rather than compound. Same architecture, opposite result.
Their advantage traces to a chain of events, not to search optimization:
Dr. Riordan holds roughly 8,823 academic citations, an h-index of 50, and 74 indexed papers. That is genuine scientific standing, and it is why their domain is the only one in this entire market with any encyclopedia citations. Research is the one component of their moat that no competitor can buy, and it is also the component that no other Panama clinic has attempted at all.
A homepage taking 45.9% of site traffic is brand-search dependency, not content strength. Their second-best page is a single condition — autism, at 1,345 visits a month, 11% of the site. Strip the brand searches and the underlying content footprint is modest.
Roughly twenty independent articles exist, and the substantive ones are unfavourable: a retracted research paper, an FDA warning letter, a multi-million dollar adverse court verdict, and sustained scrutiny from the field's most-cited independent scientist. Their brand name is also entangled with an unrelated regulatory action against a similarly named US operation, which now contaminates search results and AI summaries.
Their own reviews and complaints queries carry real volume at very low difficulty, and nobody has published a straight, factual comparison for those patients to land on.
This is why the DVC Stem model matters more to us: it is the only competitor whose traffic does not depend on a famous name, and it still outranks this one.
Section 04
Independent coverage is what convinces both Google and AI models that a clinic is real. This is a count of third-party content per competitor — press, newswire releases, podcasts, directories, published research, community discussion.
Swipe the table sideways for all columns
| Clinic | Press | Newswire | Podcasts | Directories | Research | |
|---|---|---|---|---|---|---|
| Stem Cell Institute Panama | ~20 | 2 | 6 | ~12 | 74 papers | 200+ |
| BioXcellerator | ~8 | 3 | ~9 | ~10 | 3 papers | ~0–5 |
| DVC Stem | ~6 | 0 | 0 | ~8 | 0 | dozens |
| Auragens | ~5 | 7+ | 1 | 4 | 0 | ~44 |
| Regenerate Panama | 0 | 0 | 0 | 0 | 0 | ~17 |
| BioGenesis | 0 | 0 | 0 | 0 | 0 | 0 |
Our entire third-party footprint is two web addresses — a Linktree page and a Facebook page — both of which we created ourselves. No independent article, directory listing, podcast, or forum thread references BioGenesis anywhere.
The strongest competitor has zero newswire releases, zero podcast appearances, and zero published papers. Their entire advantage is thoroughly referenced content on their own site — 8,333 ranking keywords — which health and academic publishers then cite back to them. Content is their link strategy.
Seven-plus press releases syndicated into AOL, Yahoo Finance and Morningstar, plus three award submissions each converted into further coverage. It moved them from Regenerate Panama's tier to fourth place. It is inexpensive, fast, and entirely repeatable.
The market leader's roughly twenty press mentions are mostly critical: a retracted research paper, an FDA warning letter, an adverse court verdict, and sustained scrutiny from the field's most cited independent scientist. BioXcellerator holds an FTC warning letter. Most competitor celebrity endorsements are self-published with no independent confirmation. A clinic with a clean record and published outcomes would be genuinely unique in this market.
The Stem Cell Council directory currently lists a single clinic, and its own article on Panama's top clinics names none. The Medical Tourism Association's "Stem Cell Clinics in Panama, Verified Reviews 2026" article names no clinic either. And no competitor holds a Trustpilot profile.
Also unusedOur own strongest press hook is already on the website and has never been promoted: BioGenesis is the first to offer endovascular cell therapy in the brain. No competitor makes a comparable claim, and specific verifiable firsts are exactly what trade publications cover.
Section 05
Two items on the site actively suppress how AI engines and Google treat the whole domain, and carry regulatory exposure. These should be resolved before we invest in visibility, because visibility amplifies whatever it finds.
The homepage features a patient who came to Panama after a cancer diagnosis, while the treatment and candidacy pages both list active cancer as a condition we do not treat. A reviewer reading both pages sees a clinic advertising the outcome it says it excludes. This is the specific pattern cited in FDA warning letters to stem cell clinics, and it carries advertising-substantiation exposure.
RecommendedRemove or re-caption the testimonial so it aligns with the published criteria.
Our education section frames waiting for FDA approval as a myth, states that there is no association with tumour formation without a supporting citation, and claims zero ethical concerns. Every major AI model is trained to be careful with unapproved regenerative medicine, so a page structured to rebut regulatory caution reduces the likelihood of any page on our domain being cited.
RecommendedReframe as an explanation of how Panama's MINSA framework differs from FDA approval — factual, non-adversarial, and it still answers the question patients are actually asking.
The about page gives three physicians a combined 220 words with no medical schools, board certifications, or licence numbers, and one is listed without a surname. All clinical and educational content is credited to "BioGenesis Medical Team" rather than a named doctor. For medical search this single gap caps how much expertise the site can demonstrate.
RecommendedFull physician profile pages with credentials and licence numbers, then a named medical reviewer line and review date on all twenty-plus clinical pages.
Treatment and condition pages state that clinical studies suggest meaningful benefit, with no references on the page. The education section already cites good peer-reviewed sources — they are simply absent from the commercial pages. Uncited efficacy claims in medicine are the pattern AI models are tuned to distrust.
The site states the clinic has over sixteen years of experience, while the medical director's biography on the same page states over eight years. Directory editors and journalists check exactly this kind of detail before publishing, and independent fact-checkers in this field lead with internal contradictions. It needs to be reconciled before we pitch anyone.
No treatment or condition page discloses risks or side effects. AI models preferentially cite medical sources that acknowledge limitations, so adding honest risk sections is one of the largest citability gains available to us — and it differentiates us from every competing Panama clinic.
The highest-authority "BioGenesis clinic" entity on the internet is a Florida anti-aging clinic from a Major League Baseball doping scandal, which has its own encyclopedia entry. Because we publish almost no disambiguating signals, AI models can hedge, decline to answer, or blend that framing into responses about us.
RecommendedAlways use the full name "BioGenesis Regenerative Center, Panama City, Panama"; create a Wikidata entry; complete the Google Business Profile; add a company LinkedIn page; and expand the website's machine-readable identity links from two to six or more.
Section 06
Patients increasingly ask ChatGPT, Perplexity or Google's AI summaries which clinic to use, and receive an answer without visiting any website. We tested readiness for each of the five engines that matter.
Swipe the table sideways for all columns
| Engine | Readiness | Limiting factor |
|---|---|---|
| ChatGPT web search | 58 | No encyclopedia or Wikidata entry; site not verified with Bing, which ChatGPT relies on |
| Google AI Overviews | 56 | No named authors or citations on clinical pages |
| Bing Copilot | 48 | No Bing Webmaster verification, no company LinkedIn page |
| Google Gemini | 47 | Inconsistent business listings across our three domains; videos not connected to the site |
| Perplexity | 42 | No community discussion or independent reviews anywhere |
Section 07
Not every search is worth pursuing. The clinical head terms belong to major hospital systems and will not be taken. Our opportunity is in cost, logistics, legality and specialisation — questions the incumbents answer poorly or not at all.
We hold the only structured cost comparison table among Panama clinics. The legality question is currently answered by a Colombian competitor's blog post — a dedicated page citing actual Panamanian law would take it.
The clinic-comparison questions are decided by third-party directories rather than our own pages, so the route in is being listed. Back pain is the largest low-difficulty content gap we have — roughly 1,600 monthly searches for stem cell therapy for back pain, and we have no page for it among our eleven conditions.
These resolve to Mayo Clinic, Cleveland Clinic and the NIH. Our eleven condition pages should serve patients who already found us and are evaluating treatment, not chase these terms.
Section 08
We pulled the pages that actually earn our competitors their traffic. The result points at one page type above all others, and it corrects an assumption worth correcting early.
One cost page earns DVC Stem 6,863 visits a month — 34% of their entire traffic, from a single decade-old article they keep updated. The Stem Cell Institute runs two cost pages worth another 1,531 between them. Every competitor publishes cost content. We publish none.
Swipe the table sideways for all columns
| Page | Keywords | Traffic / mo | Share of site |
|---|---|---|---|
| DVC Stem stem cell therapy cost | 481 | 6,863 | 34.4% |
| Stem Cell Institute homepage, brand searches | 217 | 5,619 | 45.9% |
| Stem Cell Institute treating autism | 166 | 1,345 | 11.0% |
| DVC Stem where do stem cells come from | 250 | 1,000 | 5.0% |
| DVC Stem what are mesenchymal stem cells | 148 | 959 | 4.8% |
| Stem Cell Institute how much do injections cost | 175 | 797 | 6.5% |
| Auragens cost of treatment in Panama guide | 38 | 12 | 0.9% |
The full Panama search cluster is roughly 10,000 searches a month, but about 45% of it is people searching for the Stem Cell Institute by name. Non-branded Panama terms come to roughly 5,000. Meanwhile the generic clinical clusters — cost, knees, back pain, knee replacement alternatives — total around 17,000, and DVC Stem proves an offshore clinic wins them without ever putting its geography in the query.
What this meansPanama terms are the beachhead: they convert and we should own them. Growth lives in the generic condition and cost terms.
Auragens wrote a Panama-specific cost guide. It earns twelve visits a month. DVC Stem's generic cost page earns 6,863. Write the definitive cost resource for the treatment, and let Panama be the answer inside it.
Back pain is the least defended opportunity in the market: difficulty 9 to 10 against roughly 2,900 monthly searches, with Regenerate Panama sitting at position 88 and the Stem Cell Institute at 19. We have no back or spine page among our eleven conditions. The knee cluster is the largest commercial opportunity at roughly 10,200 searches and difficulty in the twenties — all three competitors have knee pages, which is exactly why knees convert.
Wharton's Jelly draws roughly 2,800 monthly searches at difficulty 12 to 21, and the only competitor ranking for it sits at position 24. It is the cell source we actually use, and we have no page targeting it.
The Stem Cell Institute takes 46% of its traffic from its homepage and runs four separate pages harvesting one podcast appearance. Auragens and BioXcellerator take over half from their homepages too. DVC Stem's homepage does not even reach its top twelve — every one is a content page. They are the only competitor whose model we can execute without a celebrity, and they outrank the twenty-year incumbent.
Section 09
These waves are sequential because each depends on the one before it. Promoting a site whose authority is split three ways, or whose trust signals contradict each other, wastes the promotion.
Our brand signal is currently divided across three addresses. Until it points to one, every gain from the waves below is split rather than compounded.
This is the wave that moves authority, because it addresses the exact signals both Google and the AI engines weigh for medical information.
Cost is the highest-return page in this market by a wide margin, and published numbers are what AI engines quote. The leader's twenty-year history does not protect them if they will not publish a price.
An outcomes report or a single indexed paper would make us the most citable clinic in Panama on the one axis where the market leader is damaged rather than merely absent.
Worth doing once the foundation holds, and the Spanish-language opportunity is genuinely uncontested.
Section 10
Four measures, reviewed on a regular cycle. The second is the one most audits omit and the one that increasingly decides whether patients find us.
Tracked in Search Console on the current domain, across the full cluster of cost, legality and location searches. Success is entering the first two pages and climbing.
Ask ChatGPT, Perplexity and Gemini directly, on a schedule, which clinic they recommend for stem cell therapy in Panama, and record whether BioGenesis appears and how it is described.
Searches for our name should return our clinic, not the doping-scandal entity and not our own retired domains.
Distinct credible websites referencing us, against the milestone ladder of 178, then 333, then 450 — and appearances as a cited source in AI answers about cost and legality.